Emma Thornton
Adelaide, SA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
NK1 tachykinin receptor antagonist treatment reduces cerebral edema and intracranial pressure in an ovine model of ischemic stroke.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: March 28, 2024
Determining the Temporal Profile of Intracranial Pressure Changes Following Transient Stroke in an Ovine Model.
Journal: Frontiers in neuroscience
Published: March 31, 2019
The relationship between empathy and burnout - lessons for paramedics: a scoping review.
Journal: Psychology research and behavior management
Published: December 12, 2017
The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury.
Journal: PloS one
Published: April 16, 2017
The Role of Substance P in Secondary Pathophysiology after Traumatic Brain Injury.
Journal: Frontiers in neurology
Published: April 02, 2017
Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease.
Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease.
Journal: Neural regeneration research
Published: November 26, 2015
The Neuroprotective Properties of the Amyloid Precursor Protein Following Traumatic Brain Injury.
Journal: Aging and disease
Published: August 02, 2015
The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model.
Journal: Parkinsonism & related disorders
Published: October 03, 2013
Last Updated: 09/26/2026